PMI acquisition of gums manufacturer ‘shows company strategy on alternatives’

PMI’s acquisition of Fertin Pharma, a Danish manufacturer of gums and other oral products, indicates the company’s strategy to ensure “corporate survival” in the tobacco-alternatives sector, experts believe ...

Restricted content. Do you want to read more?